The pharmacology of the acute hyperthermic response that follows administration of 3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy') to rats - Wikidata - wikimedia - TriplyDB

The pharmacology of the acute hyperthermic response that follows administration of 3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy') to rats

The pharmacology of the acute hyperthermic response that follows administration of 3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy') to rats

http://www.wikidata.org/entity/Q28344876

about

Pharmacology of stimulants prohibited by the World Anti-Doping Agency (WADA)Toxicity of amphetamines: an update Neural and cardiac toxicities associated with 3,4-methylenedioxymethamphetamine (MDMA)Methylenedioxymethamphetamine ('Ecstasy')-induced immunosuppression: a cause for concern?Lost in translation: preclinical studies on 3,4-methylenedioxymethamphetamine provide information on mechanisms of action, but do not allow accurate prediction of adverse events in humans The norepinephrine transporter inhibitor reboxetine reduces stimulant effects of MDMA ("ecstasy") in humans Ecstasy: are animal data consistent between species and can they translate to humans?Serotonin reuptake transporter deficiency modulates the acute thermoregulatory and locomotor activity response to 3,4-(±)-methylenedioxymethamphetamine, and attenuates depletions in serotonin levels in SERT-KO rats.Critical role of peripheral vasoconstriction in fatal brain hyperthermia induced by MDMA (Ecstasy) under conditions that mimic human drug use Developmental effects of 3,4-methylenedioxymethamphetamine: a review Mechanisms mediating the ability of caffeine to influence MDMA ('Ecstasy')-induced hyperthermia in rats The role of monoamines in the changes in body temperature induced by 3,4-methylenedioxymethamphetamine (MDMA, ecstasy) and its derivatives Dancing with "death": p-methoxyamphetamine overdose and its acute management.N-substituted piperazines abused by humans mimic the molecular mechanism of 3,4-methylenedioxymethamphetamine (MDMA, or 'Ecstasy').Effects of (+/-)3,4-methylenedioxymethamphetamine, (+/-)3,4-methylenedioxyamphetamine and methamphetamine on temperature and activity in rhesus macaques 3,4-Methylenedioxymethamphetamine (MDMA) neurotoxicity in rats: a reappraisal of past and present findings.Qualitative review of serotonin syndrome, ecstasy (MDMA) and the use of other serotonergic substances: hierarchy of risk.Vesicular monoamine transporter 2 and the acute and long-term response to 3,4-(±)-methylenedioxymethamphetamine.Hyperthermia induced by 3,4-methylenedioxymethamphetamine in unrestrained rhesus monkeys.Contributions of serotonin in addiction vulnerability.Role of alpha2A-adrenoceptors in the effects of MDMA on body temperature in the mouse Gene expression analysis indicates CB1 receptor upregulation in the hippocampus and neurotoxic effects in the frontal cortex 3 weeks after single-dose MDMA administration in Dark Agouti rats.Enhanced Hyperthermia Induced by MDMA in Parkin Knockout Mice.Δ9-Tetrahydrocannabinol attenuates MDMA-induced hyperthermia in rhesus monkeys.Methylenedioxymethamphetamine (MDMA, 'Ecstasy'): a stressor on the immune system.The neuropharmacology of prolactin secretion elicited by 3,4-methylenedioxymethamphetamine ("ecstasy"): a concurrent microdialysis and plasma analysis study.Impact of ambient temperature on hyperthermia induced by (+/-)3,4-methylenedioxymethamphetamine in rhesus macaques The hidden side of drug action: brain temperature changes induced by neuroactive drugs.Evaluation of Bcl-2 Family Gene Expression in Hippocampus of 3, 4-methylenedioxymethamphetamine Treated Rats.Tolerance to 3,4-methylenedioxymethamphetamine in rats exposed to single high-dose binges.Locomotor stimulation produced by 3,4-methylenedioxymethamphetamine (MDMA) is correlated with dialysate levels of serotonin and dopamine in rat brain.Actions of 3,4-methylenedioxymethamphetamine (MDMA) on cerebral dopaminergic, serotonergic and cholinergic neurons.State-dependent and environmental modulation of brain hyperthermic effects of psychoactive drugs of abuse.Effects of MDMA on body temperature in humans Nonlinear pharmacokinetics of (+/-)3,4-methylenedioxymethamphetamine (MDMA) and its pharmacodynamic consequences in the rat.Clinically Relevant Pharmacological Strategies That Reverse MDMA-Induced Brain Hyperthermia Potentiated by Social Interaction.Bath salts: a newly recognized cause of acute kidney injury.CNS toxicity involving methylene blue: the exemplar for understanding and predicting drug interactions that precipitate serotonin toxicity.Inhibition of the dorsomedial hypothalamus, but not the medullary raphe pallidus, decreases hyperthermia and mortality from MDMA given in a warm environment.Pharmacokinetics and pharmacodynamics of 3,4-methylenedioxymethamphetamine (MDMA): interindividual differences due to polymorphisms and drug-drug interactions.

P2860

Q22251113-5D9C9826-F545-43A2-A23C-63516182CB52 Q22252794-DC62C35C-1894-484F-97CC-50797231C047 Q24619949-3264323B-AD12-46B7-A4F2-8D03FCF8F09A Q24627529-6D8EDF99-767C-48BE-B070-059F467EB383 Q26859367-F0EC78B9-92F6-4E80-8D3D-966BBA25F2BB Q28240897-30B1A9BA-0588-407E-8619-3D47658B5800 Q31033315-76682491-75CC-41F9-A524-9036A4DB4B6C Q33652473-1D48810A-F39F-4B16-A372-0546C1509FEA Q33707843-6D2B3130-01E2-4DB1-8A1B-6E8A9533C8A6 Q33923930-26379C7D-B27D-47EB-9C2A-638A1FEEFC75 Q34112855-B65F6A71-3704-4C45-A645-7892A3C4FA39 Q34112933-A3F0FB29-FBF7-4A23-887A-215961D95E12 Q34195122-C257CD8B-C8B5-4CCB-B10D-E7BBEB808B4F Q34360861-87AEB0B6-5B76-4B23-BFE1-01D0136AD14E Q34552306-2D7572E6-FE2F-4E27-8E80-42245D333538 Q34565712-51211B45-8BC2-4DBB-84CD-50F89615455E Q34647657-6E565047-AAEC-427E-8A56-14F1E83C86EF Q34760266-DA3E3FAF-42F6-4ED3-9FE3-89D1B9AE9585 Q35001625-1A43A164-147B-42B1-9464-41089C2DF0BD Q35032325-05994676-0C8C-4939-B7E6-E836649AD8B8 Q35049138-07233AD1-A121-4794-8F7B-7BF41D9A37CF Q35078880-92AD373A-FB22-4F85-A77E-57EBC66CBA52 Q35107903-311C428C-0BB8-4F8B-B834-F15282048578 Q35672856-1762FD8D-B7DF-4607-9166-AC4AB44960F2 Q35729190-2A6F4252-FC66-46D8-8D86-96E707B81905 Q35754068-62283C3C-025D-4814-9739-18570045AE97 Q36149138-F834286E-1FD0-4EAB-8EF4-57EF7A2F40A1 Q36572459-381A044F-6AA8-4073-BA73-A761C60EBBF1 Q36645266-6E15E370-0387-4DD9-9BDA-161D133E40DB Q36666580-C9A4988C-B4B0-4DC8-9895-156B98F6AF77 Q36800689-FF012A02-78DB-4CF4-8FE8-27B719422C10 Q37012610-3FC1FF1A-E3C8-47CD-AFB0-4CE03587DBDF Q37226593-44D0DD68-9FA0-43F1-97F4-6B9F71DDFEE3 Q37226598-5DE33071-46CA-4A5A-9C8D-A51C4213C3C2 Q37422671-4AE019E7-7726-404F-8487-AE5BA6BFA228 Q37458263-2E9E1C97-DF32-4759-AD64-4B17D4CB89BE Q37556263-AF19D31C-EB9A-4A94-A07E-79FAD2C3C7F8 Q37689364-AD1F26E8-F5F5-4216-B112-CE68CEE1A060 Q37714504-5470CBC6-296A-41AB-82BB-7E29AFBD036B Q38048826-7071BDA8-49ED-4979-B789-345117E0458A

P2860

The pharmacology of the acute hyperthermic response that follows administration of 3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy') to rats

http://www.wikidata.org/entity/Q28344876

description

2002 nî lūn-bûn

@nan

2002 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2002 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2002年の論文

@ja

2002年論文

@yue

2002年論文

@zh-hant

2002年論文

@zh-hk

2002年論文

@zh-mo

2002年論文

@zh-tw

2002年论文

@wuu

name

The pharmacology of the acute ...... mine (MDMA, 'ecstasy') to rats

@ast

The pharmacology of the acute ...... mine (MDMA, 'ecstasy') to rats

@en

The pharmacology of the acute ...... mine (MDMA, 'ecstasy') to rats

@nl

type

label

The pharmacology of the acute ...... mine (MDMA, 'ecstasy') to rats

@ast

The pharmacology of the acute ...... mine (MDMA, 'ecstasy') to rats

@en

The pharmacology of the acute ...... mine (MDMA, 'ecstasy') to rats

@nl

prefLabel

The pharmacology of the acute ...... mine (MDMA, 'ecstasy') to rats

@ast

The pharmacology of the acute ...... mine (MDMA, 'ecstasy') to rats

@en

The pharmacology of the acute ...... mine (MDMA, 'ecstasy') to rats

@nl

P1433

Q28344876-5D347F81-2FB8-4721-807F-B4A200929315

P1476

Q28344876-571C6A89-7C1B-4B8C-BAE3-71FC2B25788E

P2093

Q28344876-3148D530-EB6C-4D9F-ADB1-8C5BCF909755

Q28344876-6183328D-3B2C-48BD-9BC6-C712F9F6E61E

Q28344876-6C9B5E21-ED41-4048-9316-E04042A495C8

Q28344876-A4988077-26BF-4569-AFD9-54342D343CC3

Q28344876-D7929283-7ECC-4F67-A6B4-31D62193755E

Q28344876-DC7FB18A-DEAC-4C10-BCA2-47E13B0FD69B

P2860

Q28344876-03288509-873C-47BC-943C-44E723D3E8B3

Q28344876-09A2D860-32DB-41C1-AC26-DA8E304FF3AB

Q28344876-1024AFE6-A35C-4932-B4D5-FB7995F494A6

Q28344876-10A8F574-98E5-4FF0-B513-E2D9573C9BE5

Q28344876-12F19074-BA52-4CD0-A6D8-8A943C8B7AA6

Q28344876-14876504-7124-420D-A869-96FC991677ED

Q28344876-1AF53A85-549C-446A-BDE9-890F4306118F

Q28344876-25BA8D18-C6AD-44AC-AAB9-2DFE027707C6

Q28344876-281DA491-973F-4D31-B493-E1F6F8DC8CD0

Q28344876-2AEBF1D0-8759-4538-AE60-06D3811257BA

P304

Q28344876-FEF42C0B-73C3-4C1D-AAEC-D12FA70DB893

P31

Q28344876-A7E05AD5-6EB3-4C17-B84C-D52E512F681D

P356

Q28344876-64902081-7BC8-4D38-8209-97EB7F17D6AA

P407

Q28344876-47E446F8-6FB1-4BC0-8994-3BC3BFE2234E

P433

Q28344876-EF941917-A231-4523-921D-C122A9D813AF

P478

Q28344876-7EE40014-2BD3-4CE4-BEB0-65FFC5BDA52A

P577

Q28344876-8C6E2E56-45A2-4B92-8369-CB9F76C51830

P5875

Q28344876-64CA1036-6C8A-461B-B4EC-9084F76AC2C5

P698

Q28344876-2087D8F5-29EE-4F4E-B3B7-C0AD8C272B47

P921

Q28344876-8C6A7634-54A6-4A80-AD9C-5B2E46912786

P932

Q28344876-A293DD4B-6610-4C31-BEB1-D021EFF39F6B

P356

P1433

British Journal of Pharmacology

P1476

The pharmacology of the acute ...... mine (MDMA, 'ecstasy') to rats

@en

P2093

A Richard Green

http://www.w3.org/2001/XMLSchema#string

Annis O Mechan

http://www.w3.org/2001/XMLSchema#string

Blanca Esteban

http://www.w3.org/2001/XMLSchema#string

Esther O'Shea

http://www.w3.org/2001/XMLSchema#string

J Martin Elliott

http://www.w3.org/2001/XMLSchema#string

M Isabel Colado

http://www.w3.org/2001/XMLSchema#string

P2860

5-HT loss in rat brain following 3,4-methylenedioxymethamphetamine (MDMA), p-chloroamphetamine and fenfluramine administration and effects of chlormethiazole and dizocilpine

The mechanisms involved in the long-lasting neuroprotective effect of fluoxetine against MDMA ('ecstasy')-induced degeneration of 5-HT nerve endings in rat brain

Striatal dopamine release in vivo following neurotoxic doses of methamphetamine and effect of the neuroprotective drugs, chlormethiazole and dizocilpine

Effect of GBR 12909 and fluoxetine on the acute and long term changes induced by MDMA ('ecstasy') on the 5-HT and dopamine concentrations in mouse brain.

5-HT2 receptors exert a state-dependent regulation of dopaminergic function: studies with MDL 100,907 and the amphetamine analogue, 3,4-methylenedioxymethamphetamine.

Effects of various dopamine uptake inhibitors on striatal extracellular dopamine levels and behaviours in rats.

Effects of the enantiomers of MDA, MDMA and related analogues on [3H]serotonin and [3H]dopamine release from superfused rat brain slices.

Carrier-dependent and Ca(2+)-dependent 5-HT and dopamine release induced by (+)-amphetamine, 3,4-methylendioxymethamphetamine, p-chloroamphetamine and (+)-fenfluramine.

The hyperthermic and neurotoxic effects of 'Ecstasy' (MDMA) and 3,4 methylenedioxyamphetamine (MDA) in the Dark Agouti (DA) rat, a model of the CYP2D6 poor metabolizer phenotype

Changes in body temperature after administration of adrenergic and serotonergic agents and related drugs including antidepressants: II.

P304

170-80

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/SJ.BJP.0704442

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

135

http://www.w3.org/2001/XMLSchema#string

P577

2002-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

11570971

http://www.w3.org/2001/XMLSchema#string

P698

11786492

http://www.w3.org/2001/XMLSchema#string

P921

P932

1573106

http://www.w3.org/2001/XMLSchema#string